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Background: Severe (PiZZ) and moderate (PiSZ) alpha-1-antitrypsin (AAT) deficiency predis-
pose to lung emphysema, especially in smokers. We hypothesized that multi-slice computed
tomography (CT) might be superior to pulmonary function tests (PFT) to detect lung emphy-
sema in AAT-deficient individuals at the age of 32 years.
Methods: A subgroup of PiZZ and PiSZ individuals identified during the Swedish newborn
screening programme in 1972e74 underwent multi-slice CT and PFT at the age of 32 years.
From the CT scans the percentile density at 15% (PD15) and the relative area below e910
Hounsfield Units (RA910 HU) were calculated. The results of PFT and CT were compared
between the AAT-deficient individuals and an age-matched control group.
Results: Twenty-five PiZZ, 11 PiSZ and 17 PiMM individuals participated in the study. All Pi
subgroups had normal lung function. The mean PD15 was 81 (SD 22) g/L in the PiZZ individuals,
96 (SD 35) g/L in the PiSZ individuals and 79 (SD 17) g/L in the PiMM individuals (ns), and the RA-
910 were 30 (SD 18)%, 24 (SD 20)%, and 32 (SD 18)%, respectively (ns). For the never-smokersin deficiency; PFT, Pulmonary function tests; CT, Computed tomography; Pi, Protease inhibitor;
obstructive pulmonary disease; PD15, The 15th percentile point; RA, Relative area; FEV1, Forced
; TLC, Total lung capacity; FRC, Functional respiratory capacity; RV, Residual volume; DLCO, Diffusing
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CT lung densitometry in young adults with alpha-1-antitrypsin deficiency 75subgroups, in the PiZZ (nZ 23), PiSZ (nZ 8) and PiMM (nZ 12), the mean PD15 were 95 (SD 35)
g/L, 81 (SD 22) g/L, and 75 (SD 12) g/L, respectively (ns). PD15 was significantly correlated to
CT derived lung size (r Z 0.72; p < 0.001).
Conclusions: CT densitometry revealed no signs of emphysema and no differences between the
AAT-deficient individuals identified by neonatal screening and age-matched control subjects.
ª 2010 Elsevier Ltd. All rights reserved.Introduction
Alpha-1-antitrypsin (AAT), a glycoprotein mainly syn-
thesised in the liver, protects lung tissue from destruction
by neutrophil elastase.1,2 Individuals with severe AAT defi-
ciency, phenotype PiZZ, are susceptible to develop
emphysema. Especially smokers have an increased risk and
there have been reports of signs of chronic obstructive
pulmonary disease (COPD) as early as in the fourth decade
of life.3,4 In the moderate form, PiSZ, smoking increases the
otherwise low risk of developing emphysema.5
For several years, the measurement of lung function
parameters has been used to diagnose and follow COPD. In
the seventies, computed tomography (CT) was introduced
to provide a quantitative analysis of lung density6 and in
recent years, use of CT in diagnosing and following COPD
has increased.
Multi-slice CT is highly sensitive for the detection of small
regions of emphysema by the measurement of lung density.
There is a linear relation between density and Hounsfield
Units (HU), 1000 HU corresponds to the density of air and
0 HU to that of water. By adding 1000 to the value in Houns-
fieldunits, thedensity canbeexpressed in g/L, e.g.,880HU
corresponds to 120 g/L. Considered more sensitive than
spirometry in revealing early and small alterations in lung
parenchyma, CT has since 1992 been used to evaluate lung
disease in AAT-deficient individuals.7e9
For quantitative analysis, the two most sensitive CT
parameters are the percentile density (PD) and the relative
area (RA). The percentile density is the cut-off point at
which a given percentage of the histogram has lower
densities, for example the 15th percentile density is the
density value in HU at which 15% of the voxels (3D pixels)
have lower densities. The relative area is based on the
concept of “density mask” and is defined as the percentage
of pixels below a given threshold in HU, originally set at
910 HU by Mu¨ller et al.10
The primary lung function parameters related to
obstructive lung disease are FEV1 (forced expiratory volume
in 1 s), the FEV1/VC (vital capacity) ratio and DL,CO (diffu-
sion capacity for carbon monoxide). Of these DL,CO is better
correlated cross-sectionally to CT11,12 than FEV1, although
both have been shown to correlate well in AAT-deficient
patients with emphysema.13
This cohort of 32-year-old individuals with severe (PiZZ)
and moderate (PiSZ) AAT deficiency was identified by
neonatal screening and their pulmonary function has been
examined every four years from the age of 18. FEV1 and FVC
have been normal, both expressed as percentage of pre-
dicted values and compared to an age-matched control
group.14 However, we have recently found decreased KCO
(transfer coefficient for carbon monoxide) and FEV1/VC aswell as increased VC in PiZZ current smokers, compared to
PiZZ never-smokers.15
The primary aim of this study was to investigate lung CT
densitometry and lung function in AAT-deficient individuals
and age-matched controls.
Study subjects and methods
Study population
From 1972 until 1974, all 200,000 new-born Swedish infants
were screened for AAT deficiency. The cohort of AAT-defi-
cient individuals, comprising 128 PiZZ (including 2 PiZNull)
and 55 PiSZ (including 1 PiSNull) subjects, were asked to
undergo multi-slice CT of the thorax and lung function
examination at the age of 32.
Three hundred control subjects were randomly selected
from the Swedish population registry. Ninety of them had
taken part in a previous study at the Department of Respi-
ratory Medicine in Malmo¨.14 Their plasma AAT levels were
determined and six individuals, found to be heterozygous
PiMZ, were excluded. The remaining 84 subjects with normal
AAT levels were invited to participate in this study.
Self-reported smoking habits were obtained via a ques-
tionnaire, which included questions on whether the
participants had smoked, and if so, when they had started
and, where applicable, age at the time of giving up. The
number of cigarettes per day during the period of smoking
was reported.
The study was conducted in accordance with the Hel-
sinki Declaration, and approved by the Regional Ethical
Review Board in Lund, Sweden. Approval was obtained from
the Radiation Protection Committee. All participants in the
study gave their signed, informed consent.
Computed tomography
Multi-slice CT was performed at the Department of Radi-
ology at the University Hospital in Malmo¨. The examinations
were performed on a multi-detector, Siemens Somaton
Sensation 64 (Erlangen, Germany) scanner at full inspira-
tion (i.e., TLC) after three deep inhalation manoeuvres.
The following parameters were used: effective mAs 20, kV
120, estimated average scan time 7 s, reconstructed slice
thickness 5 mm, increment 2.5 mm, rotation time 0.5 s,
pitch 1.5, collimation 64  0.6 mm, B10f reconstruction
filter (very smooth), FOV 300 mm and acquisition in the
caudalecranial direction to avoid breathing artifacts at the
level of the diaphragm. The images were processed
with Pulmo-CMS software (Medis Specials, Leiden, The
Netherlands) by an experienced physician (S.D.), blinded to
Table 1 Demographic information about the participants.
PiZZ
(n Z 25)
PiSZ
(n Z 11)
PiMM
(n Z 17)
Women/Men 10/15 4/7 6/11
Age, yrs 32 (31e33) 32 (31e33) 32 (31e33)
Smoking habits
Current smokers 1 0 4
Ex-smokers 1 3 1
Never-smokers 23 8 12
Age is presented as the median (range).
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matically by a so-called region growing algorithm. The
frequency distribution of the densities in the detected left
and right lung was recalibrated based on the densities
measured in the air and the descending aorta. From this
distribution, the 15th percentile point (PD15) was calcu-
lated as a measure of lung density. In addition, the relative
area below 910 (RA910) was calculated. Lung volume was
determined by adding the volumes of all voxels within the
lungs, accounting for overlap between slices.
Pulmonary function tests
In all participants, pulmonary function tests were per-
formed at the Department of Physiology at the University
Hospital in Malmo¨. Lung function measurements, including
FEV1, VC, TLC, FRC, RV and DL,CO, were performed
according to the recommendations of the European
Respiratory Society (ERS).16 FEV1 and VC were examined
15 min after bronchodilation with a b2-agonist (Bricanyl
ª
1.0 mg). Post bronchodilation results are reported. The
values of FEV1, FEV1/VC ratio, TLC, FRC, RV and DL,CO are
expressed as the percentage of predicted values using the
European Coal and Steel Community’s summary equa-
tions17 and the FEV1/VC ratio is also expressed as
percentage.Table 2 Results from pulmonary function tests and CT densitom
PiZZ (n Z 25)
FEV1, % predicted 109 (12)
VC, % predicted 111 (14)
FEV1/VC, % 83 (4.6)
DL,CO, % predicted 92 (9)
KCO, % predicted 110 (4)
TLC, %predicted 106 (13)
FRC, % predicted 104 (21)
RV, % predicted 103 (19)
LV, L 6.6 (1.5)
Lung density, g/L 145 (28)
PD15, g/L 81 (22)
RA910 HU, % 30 (18)
Lung function and CT densitometry data are presented as means (SD)
diffusion capacity of carbon monoxide; LV: lung volume measured b
density at the 15th percentile; RA910: relative area below 910 HU.Statistical analysis
Statistical analyses were performed using SPSS 12.0.1
software. Testing for normal distribution was done using
ShapiroeWilk’s test. In the comparison of continuous vari-
ables ManneWhitney and KruskaleWallis tests were used.
Correlation coefficients were computed for the comparison
of CT results with lung function values. Multiple regression
analysis was used to determine independent effects of
diffusing capacity, FEV1 and CT derived lung volume on
PD15. The c
2-test was used for analysing categorical
variables.
Results
Demographic data are shown in Table 1. Twenty-five of 128
PiZZ, 11 of 55 PiSZ and 17 of 84 PiMM subjects participated.
The most common reasons not to participate were lack of
time and lack of interest because the subjects felt that
they were in good health. Furthermore, as the AAT-defi-
cient subjects live in all parts of the country, the incon-
venience of travelling to Malmo¨ was considered as a hinder
to participation.
There was no age difference between the Pi subgroups.
In the entire group, the age ranged from 31 to 33 years,
with a mean of 32. There were fewer women than men in
all Pi subgroups, with no statistically significant difference
in gender ratios between the Pi subgroups.
The results of the lung function tests and CT examina-
tions are shown in Table 2. Comparison of the different Pi
subgroups revealed no statistically significant differences in
either lung function or multi-slice CT parameters. The
results of the lung function tests and CT densitometry in
never-smokers are shown in Table 3. All differences
between the Pi subgroups were statistically insignificant.
The individual results in the current and former smokers are
shown in Table 4. The only PiZZ current smoker had the
lowest PD15 of 60 g/L. She also had the highest lung volumes
with a total lung capacity of 131% of the predicted value
and a residual volume of 145% of predicted. One of theetry.
PiSZ (n Z 11) PiMM (n Z 17)
108 (14) 109 (12)
110 (13) 109 (10)
83 (6) 85 (5)
94 (14) 92 (14)
111 (2) 111 (4)
102 (10) 102 (8)
92 (15) 94 (21)
91 (14) 96 (21)
6.1 (2.0) 6.4 (1.6)
164 (42) 142 (22)
96 (35) 79 (17)
24 (20) 32 (18)
. FEV1: forced expiratory volume in 1 s; VC: vital capacity; DL,CO:
y multi-slice CT; L: liter; HU: Hounsfield Units; PD15: pulmonary
Table 3 Lung function and lung density in the never-smoking PiZZ, PiSZ and PiMM individuals. Means and standard deviations
(SD) are shown. All differences between the Pi subgrups are insignificant.
PiZZ (n Z 23) PiSZ (n Z 8) PiMM (n Z 12)
FEV1 (% predicted) 109 (13) 104 (14) 112 (SD 10)
VC (% predicted) 110 (14) 106 (12) 110 (SD 9)
FEV1/VC Ratio 0.84 (0.04) 0.82 (0.06) 0.85 (0.03)
FEV1/VC (% predicted) 102 (5) 100 (4) 102 (4)
TLC (% predicted) 104 (12) 99 (10) 103 (8)
RV (% predicted) 102 (18) 91 (15) 97 (23)
KCO (% predicted) 110 (4) 111 (2) 111 (4)
PD15 (g/L) 81 (22) 95 (35) 75 (12)
RA910 (%) 30 (18) 24 (21) 35 (SD 14)
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61 g/L. He had normal lung volumes.
There was a significant correlation between PD15 and CT
derived lung volume (p < 0.001; Fig. 1). In univariate
analysis PD15 was also correlated to diffusing capacity
(r Z 0.72; p < 0.001) and to FEV1 (r Z 0.34; p < 0.05)
but in multivariate analysis, only the correlation to CT
derived lung volume remained significant.
Discussion
Our results in a group of 32-year-old individuals with severe
and moderate AAT deficiency showed no differences in CT
densitometry compared to an age-matched control group.
This cohort of AAT-deficient individuals has so far not been
examined by multi-slice CT and to our knowledge, multi-
slice CT has not been done in a group of young AAT-defi-
cient individuals with normal lung function.
The cohort, from whom these individuals originate, has
reported a low smoking frequency.14 However, none of the
five PiSZ current smokers and only one of the seven PiZZ
current smokers participated in this study. The only PiZZ
smoker had the lowest PD15, and also showed high lung
volumes. On the other hand, the next lowest PD15 was
measured in one of the three PiMM current smokers. He had
smoked more than the PiZZ smoker (Table 4).
To assess the natural course of AAT deficiency, lung
density and lung function were compared between the
never smokers. No statistically significant differences were
found between the Pi subgroups (Table 3).Table 4 Sex, age, PD15, RA910 and lung function in the curren
Smoking Pi Sex Age
(Years)
Pack-
years
PD15
(g/L)
RA910
(HU)
FEV1
(% pred)
VC
(% pre
Current ZZ F 32 2.4 60 52 108 127
Former ZZ F 32 5.0 87 18 113 121
Former SZ M 31 12.0 76 26 120 128
Former SZ F 32 1.5 143 1 120 115
Former SZ F 31 4.0 70 40 116 119
Current MM F 32 12.3 108 5 115 112
Former MM M 32 0.2 62 52 132 121
Current MM M 32 8.8 111 6 95 91
Current MM M 32 17.8 102 7 93 96
Current MM M 31 6.8 61 53 90 109
M Z Male; F Z Female.We found a high correlation between lung density and
CT derived lung volume. Thus, low lung density is not
necessarily a sign of disease. Stolk et al. have previously
found a relationship between lung density and lung volume
in healthy individuals,18 suggesting that lung density is
dependent on the anatomical size of the lungs in healthy
individuals. His findings are in accordance with our study, in
which no high lung densities and large lung volumes were
seen in the same subject (see Fig. 1). No correlations were
found between lung density and lung function parameters
in multiple regression analysis (by including lung CT volume
as covariate), which was expected in these healthy
individuals.
We chose to analyse the relative area below 910 HU.9
An RA of 950 HU has been shown to be more sensitive
and better correlated with macroscopic as well as micro-
scopic signs of emphysema11 but in this cohort of 32-year-
old individuals, a pixel index of 950 HU would probably be
too low to give useful information, because of its inherent
cut-off effect at 0%. Even if CT densitometry is considered
more sensitive in detecting disease, lung function param-
eters were normal and severely decreased density was
unlikely to be found.
There is an ethical consideration concerning an exami-
nation of healthy individuals by radiation techniques.
Because the individuals in this cohort have an inherited
increased risk of developing emphysema, it is important to
know at which age the first signs of emphysema appear.
Even though they had normal lung function there was
a possibility that early alterations could be detected by CTt and former smokers.
d)
FEV1/VC
(Ratio)
FEV1/VC
(% pred)
TLC
(% pred)
RV
(% pred)
Diff.cap
(% pred)
KCO
(% pred)
0.74 89 131 145 87 120
0.82 98 112 97 91 113
0.78 95 116 106 109 111
0.91 109 101 75 72 111
0.85 102 111 91 97 110
0.89 105 98 69 75 108
0.92 109 114 91 110 107
0.87 98 87 84 75 109
0.80 99 98 120 77 109
0.68 80 100 100 92 114
Figure 1 Relationship between lung density at the 15th
percentile point (PD15) and lung volume measured by
computed tomography (CT) in the PiZZ, PiSZ and PiMM
subjects. r: Spearman’s correlation coefficient.
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the general population is needed even if in the healthy
control group, decreased lung density was not expected.
We also found the lowest density measurements in the PiZZ
individuals. Despite this ethical concern, fear of exposure
to radiation was not specified as a reason for not partici-
pating, other reasons being more common. Furthermore,
efforts to minimize the radiation dose have been made, and
one examination with the low dose multi-slice CT technique
used in this study corresponds to about five months of
background radiation, which is less than a conventional CT
scan examination. Future examinations are necessary to
detect possible changes of the lung parenchyma in this
cohort of AAT-deficient individuals.
With a new examination technique such as CT densitom-
etry, reference values have not yet been established.
Different values of percentile density and relative area are
used and a consensus is still to be reached. Awaiting stan-
dardization, comparison with a control group is necessary.
Multi-slice CT has been validated as an appropriate tech-
nique for the assessment of emphysema in the lungs18,19 and
a standardized protocol has been defined for 5 different CT
scanners in a research project supported by the European
Commission (SPREAD, QLG-2000-01752).20 The major
advantage of the multi-slice CT technique is that the entire
thorax is imaged during one single breath-hold, and three-
dimensional reconstructions, lung volume measurements
and quantification of lung disorders can be obtained.
In conclusion, at 32 years of age, this cohort appears
healthy when examined by multi-slice computed tomog-
raphy and lung function tests.
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